Tag: Mylan

FTC gives conditional approval to Mylan’s acquisition of Upjohn from Pfizer

pharmanewsdaily- October 31, 2020

The US Federal Trade Commission (FTC) has granted conditional approval for Dutch pharma company Mylan’s acquisition of Upjohn, the off-patent branded and generic established medicines ... Read More

Mylan gets favorable court decision in Biogen’s Tecfidera patent case

pharmanewsdaily- June 19, 2020

Dutch generic drugmaker Mylan said that the US District Court for the Northern District of West Virginia has invalidated Biogen's Tecfidera patent U.S. Patent No. ... Read More

Mylan, Biocon get FDA approval for Semglee in type 1 and 2 diabetes

pharmanewsdaily- June 12, 2020

Mylan and Biocon have secured approval from the US Food and Drug Administration (FDA) for Semglee (insulin glargine injection) in vial and pre-filled pen presentations ... Read More

Mylan launches Humira biosimilar Hulio across Europe

pharmanewsdaily- October 22, 2018

Mylan has launched Hulio, a biosimilar to AbbVie's Humira (adalimumab), in major markets in Europe, a month after its approval from the European Commission for ... Read More

Mylan’s generic of Allergan's vaginal estrogen cream Estrace gets FDA nod

pharmanewsdaily- December 30, 2017

Mylan has secured the US FDA approval for Estradiol Vaginal Cream USP, 0.01%, the generic version of Allergan's vaginal estrogen cream – Estrace for the ... Read More

Mylan launches generic Benicar and Benicar HCT high BP tablets in US

pharmanewsdaily- November 6, 2016

Global pharmaceutical company Mylan has launched the hypertension tablets Benicar and Benicar HCT in the US. Benicar and Benicar HCT are the first generic version ... Read More